HELIOS-B-Subgruppenanalysen zeigen konsistenten Nutzen von Vutrisiran bei ATTR-CM – neue ESC-Guidelines geben höchste ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results